Photodynamic Therapy (PDT) Cholangiocarcinoma Registry

Status unconfirmed

Conditions studied: Unresectable Cholangiocarcinoma, Biliary Obstruction, Stent Obstruction, Biliary Stricture

In brief

Currently, very few centers offer Photodynamic therapy for unresectable Cholangiocarcinoma in the United States. Several European studies have reported the efficacy and safety of Photodynamic Therapy (PDT) for Cholangiocarcinoma, however, only a few studies have reported the same in the United States. The establishment of a registry to capture all PDT cases within and outside US can help the investigators evaluate a larger and non-ambiguous sample population. This would help the investigators evaluate the technical success rates, clinical success rates, feasibility and safety of PDT for unresectable cholangiocarcinoma. With more endoscopists considering PDT as a therapeutic option along with adjuvant treatment for cholangiocarcinoma, there is a need to further evaluate the efficacy and safety of such combined procedures as well. The ultimate objective is to assess if PDT with or without additional or adjuvant treatment options prolongs survival duration and improves quality of life in patients with unresectable cholangiocarcinoma. This multicenter registry has been initiated: * To document the impact of PDT on the clinical management of unresectable cholangiocarcinoma. * To assess the clinical and technical success rates of PDT for unresectable cholangiocarcinoma.

Key facts

Study ID
NCT01524146
Run by
Weill Medical College of Cornell University
People needed
200
Starts
2011-11-01
Expected to finish
2018-12-30
Last updated by the study team
2017-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.